Surface Oncology

Surface Oncology was created to advance next-generation approaches to cancer immunotherapy based on proprietary insights about novel immunotherapy targets and emerging areas of cancer immuno-biology. Together with world-leading scientific founders, the Company is advancing multiple preclinical programs that target novel mechanisms shown to play vital roles in tumor immune-evasion. Surface is based in Cambridge, Mass.
Cambridge, US
24 (est)+10%

Surface Oncology Locations

Cambridge, US

Surface Oncology Metrics

Surface Oncology Summary

Founding Date


Total Funding

$35 M

Latest funding size

$35 M

Time since last funding

almost 2 years


Surface Oncology News

Surface Oncology Company Life